Share Email Print
cover

Proceedings Paper

Use of Laser Photomodulation in the Evolution of Oral Mucositis Associated to Cyclophosphamide, Methotrexate, 5-Fluouracil - CMF in 5 Fluouracil + Adriamycin + Cyclophosphamide - FAC Chemotherapy Protocols in Patients with Breast Cancer
Author(s): Maria de Fátima Lima Ferreira; Fabiola Bastos de Carvalho; Susana C. P. S. de Oliveira; Juliana S. C. Monteiro; Gustavo M. P. Santos; Maria F. M. Gesteira; Tereza Cristina Teixeira Maia; Antônio L. B. Pinheiro
Format Member Price Non-Member Price
PDF $14.40 $18.00
cover GOOD NEWS! Your organization subscribes to the SPIE Digital Library. You may be able to download this paper for free. Check Access

Paper Abstract

The aim of this study was to evaluate the efficacy of the laser photobiomodulation (FBML) in prevention and treatment of oral mucositis induced by chemotherapy protocols CMF (cyclophosphamide, methotrexate, 5-Fluouracil) and FAC (5 Fluouracil + Adriamycin + Cyclophosphamide) in cancer patients breast. We selected 28 patients treated at the Center for High Complexity (CACON), who underwent 6 cycles of 21 days of treatment, with diagnosis of infiltrating ductal carcinoma (ICD C50.9). Were randomly divided into three groups: Group A - eight patients (Protocol FAC + Dental protocol of CACON + Laser), Group B - 6 patients (Protocol CMF + Dental protocol of CACON + Laser), Group C - was divided into two sub-groups: Group C1 with 8 patients (Control Group 1: FAC + Dental protocol o CACON) and group C2 with 6 patients (control group 2: Protocol CMF + Dental protocol of CACON). Patients in Group A and B were use of preventive FBML 24 hours before the start of chemotherapy cycle, then every 48 hours and was extended up to one week following completion of chemotherapy. The groups A and B, presented oral mucositis grade 0 (64.29%) p = 0.07, grade I (7.14%), grade II (14.29%), grade III (7.14 %), grade IV (7.14%) compared to group C, who presented mucositis grade 0 (35.71%) in the initial evaluation with p = 0.10, grade I (21.43%), grade II (28.57%), grade III (14.29%), grade IV (0.00%), patients who used the FBML as a preventive and therapeutic showed a reduction and pain relief in 42.86%. It is concluded that the low power laser when used preventively or as therapy and showed immediate relief of pain and accelerate tissue repair.

Paper Details

Date Published: 5 March 2013
PDF: 7 pages
Proc. SPIE 8569, Mechanisms for Low-Light Therapy VIII, 85690O (5 March 2013); doi: 10.1117/12.2005274
Show Author Affiliations
Maria de Fátima Lima Ferreira, Federal Univ. of Alagoas (Brazil)
Univ. Federal da Bahia (Brazil)
Fabiola Bastos de Carvalho, Univ. Federal da Bahia (Brazil)
Susana C. P. S. de Oliveira, Univ. Federal da Bahia (Brazil)
National Institute of Optics and Photonics (Brazil)
Juliana S. C. Monteiro, Univ. Federal da Bahia (Brazil)
National Institute of Optics and Photonics (Brazil)
Gustavo M. P. Santos, Gonçalo Muniz Institute (Brazil)
Maria F. M. Gesteira, Univ. Federal da Bahia (Brazil)
National Institute of Optics and Photonics (Brazil)
Tereza Cristina Teixeira Maia, Federal Univ. of Alagoas (Brazil)
Antônio L. B. Pinheiro, Univ. Federal da Bahia (Brazil)
National Institute of Optics and Photonics (Brazil)
Camilo Castelo Branco Univ. (Brazil)


Published in SPIE Proceedings Vol. 8569:
Mechanisms for Low-Light Therapy VIII
Michael R. Hamblin; Juanita Anders; James D. Carroll; Praveen R. Arany, Editor(s)

© SPIE. Terms of Use
Back to Top